Endocrine Neoplasia & HD

Medicine & Life Sciences

1. Thyroid Neoplasms 100%
2. Medullary Thyroid cancer 85%
3. Neoplasms 53%
4. Pheochromocytoma 45%
5. Paraganglioma 37%
6. Adrenocortical Carcinoma 36%
7. Thyroid Gland 32%
8. Anaplastic Thyroid Carcinoma 30%
9. Mutation 29%
10. Calcitonin 27%
11. Therapeutics 26%
12. Multiple Endocrine Neoplasia Type 2a 24%
13. Papillary Thyroid Cancer 23%
14. Survival 18%
15. Genes 18%
16. Neoplasm Metastasis 18%
17. lenvatinib 18%
18. Protein-Tyrosine Kinases 16%
19. Iodine 15%
20. cabozantinib 15%
21. Exons 14%
22. Multiple Endocrine Neoplasia 13%
23. Calcitonin Gene-Related Peptide 13%
24. Multiple Endocrine Neoplasia Type 1 13%
25. Proto-Oncogenes 13%
26. Sorafenib 12%
27. Bone and Bones 12%
28. Parathyroid Neoplasms 12%
29. Thyroidectomy 11%
30. Thyroid Nodule 11%
31. Phosphotransferases 10%
32. Progression-Free Survival 10%
33. Primary Hyperparathyroidism 10%
34. Drug Therapy 10%
35. Radiotherapy 10%
36. Thyrotropin 9%
37. Hypercalcemia 9%
38. Adrenalectomy 9%
39. Guidelines 9%
40. RNA 8%
41. Genetic Testing 8%
42. Clinical Trials 8%
43. Hypothyroidism 8%
44. Neck 8%
45. Recurrence 8%
46. Serum 8%
47. N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine 8%
48. Fine Needle Biopsy 8%
49. Confidence Intervals 8%
50. Germ-Line Mutation 8%
51. Pituitary Neoplasms 7%
52. Diphosphonates 7%
53. von Hippel-Lindau Disease 7%
54. pembrolizumab 7%
55. Cushing Syndrome 7%
56. Receptor, Fibroblast Growth Factor, Type 1 7%
57. Safety 7%
58. Thyroid Hormones 7%
59. dabrafenib 7%
60. Vemurafenib 7%
61. Familial medullary thyroid carcinoma 7%
62. Polypyrimidine Tract-Binding Protein 6%
63. Proteins 6%
64. Phenotype 6%
65. p21-Activated Kinases 6%
66. Breast Neoplasms 6%
67. Multiple Endocrine Neoplasia Type 2b 6%
68. Neuroendocrine Tumors 6%
69. Sertoli Cells 6%
70. Glioblastoma 6%
71. Thyroglobulin 6%
72. trametinib 6%
73. Thyrotropin Alfa 6%
74. Cell Line 6%
75. Parathyroidectomy 5%
76. Hyperparathyroidism 5%
77. Sunitinib 5%
78. Osteoporosis 5%
79. Adrenocorticotropic Hormone 5%
80. Pediatrics 5%
81. Osteoblasts 5%
82. Pharmaceutical Preparations 5%
83. Messenger RNA 5%
84. Codon 5%
85. Fetal Proteins 5%
86. Acromegaly 5%
87. Calcium 5%
88. Carcinogenesis 5%
89. Cancer Survivors 5%
90. Osteogenesis 5%
91. Insulin 5%
92. Congenital Hyperinsulinism 5%
93. Immunotherapy 5%
94. Carcinoma 5%
95. Sulfonylurea Receptors 5%
96. DNA 5%
97. Adrenal incidentaloma 5%
98. Histone Demethylases 5%
99. Hypoparathyroidism 5%
100. Adenoma 5%